Partneringdesk Deals and Alliances In Genitourinary And Gynecological Diseases

Partneringdesk deals and alliances in genitourinary and gynecological diseases provides an in-depth view of over 640 deals and alliances announced in genitourinary and gynecological diseases between 2001 and 2006, in a clear and accessible PDF format. Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in genitourinary and gynecological diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment of deal-making trends in the last five years identifying active partners tracking competitor activity benchmarking deals Partneringdesk deals and alliances in genitourinary and gynecological diseases brings all the relevant partnering deals into one place, providing a ready reference to deal making in oncology. Report scope The report contains: fully categorized deal overviews financial information where disclosed company profiles of the top 25 dealmakers in the report specialized indexes by company, development stage, deal type and industry sector. wider coverage of Japanese deals courtesy of JCN Forecasts, projections, market estimates This report provides a series of charts with analyses detailing market trends in genitourinary and gynecological diseases deal making over the period of 2001 to 2006. Methodology This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources.

Additional Information

Who should buy the report
This report is essential reading for board and executive management, and individuals in:

• business development
• licensing/partnering
• deal making
• business strategy
• marketing and promotion
• distribution and manufacturing (including contract services).

Companies analyzed/mentioned
Abbott Laboratories
AusAm Biotechnologies
AXM Pharma
CR Bard
DaVita Inc
Digene Corp
Eli Lilly and Company
Endocare Inc
Ferring Pharmaceuticals
Gambro
Genzyme Corporation
GlaxoSmithKline
IRIS International
King Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
KV Pharmaceutical
MediCult
NexMed
Novartis AG
Paladin Labs Inc
Pfizer Inc
Roche
Rockwell Medical Technologies Inc
Schering AG
Women First HealthCare